132 related articles for article (PubMed ID: 37824767)
1. EFFECT OF LACTATE DEHYDROGENASE INHIBITION BY OXAMATE ON LEWIS LUNG CARCINOMA CELLS WITH DIFFERENT METASTATIC POTENTIAL.
Kolesnik DL; Prokhorova IV; Pyaskovskaya ON; Solyanik GI
Exp Oncol; 2023 Oct; 45(2):242-251. PubMed ID: 37824767
[TBL] [Abstract][Full Text] [Related]
2. Oxamate, an inhibitor of lactate dehydrogenase, can stimulate M2 polarization of peritoneal macrophages in mice with Lewis lung carcinoma.
Solyanik GI; Karaman ОМ; Yakshibaeva YR; Pyaskovskaya ON; Kolesnik DL
Exp Oncol; 2021 Sep; 43(3):270-273. PubMed ID: 34591427
[TBL] [Abstract][Full Text] [Related]
3. Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro.
Kolesnik DL; Pyaskovskaya ON; Gorbach O; Solyanik GI
Exp Oncol; 2020 Mar; 42(1):35-39. PubMed ID: 32231186
[TBL] [Abstract][Full Text] [Related]
4. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
5. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
6. 2-Deoxy-D-glucose enhances dichloroacetate antitumor action against Lewis lung carcinoma.
Pyaskovskaya ON; Kolesnik DL; Fedorchuk AG; Prokhorova IV; Solyanik GI
Exp Oncol; 2016 Sep; 38(3):176-80. PubMed ID: 27685525
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma.
Kolesnik DL; Pyaskovskaya ON; Yakshibaeva YR; Solyanik GI
Exp Oncol; 2019 Mar; 41(1):14-19. PubMed ID: 30932416
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment changes tumor cell sensitivity to action of energy metabolism modifiers.
Pyaskovskaya ON; Kolesnik DL; Prokhorova IV; Burlaka АP; Gorbach OI; Solyanik GI
Exp Oncol; 2020 Sep; 42(3):192-196. PubMed ID: 32996739
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of changes of antioxidant system indexes during the growth of two Lewis lung carcinoma variants.
Pyaskovskaya ON; Sorokina LV; Kolesnik DL; Boichuk IV; Melnikov OR; Solyanik GI
Exp Oncol; 2014 Mar; 36(1):29-33. PubMed ID: 24691281
[TBL] [Abstract][Full Text] [Related]
10. Role of tumor/endothelial cell interactions in tumor growth and metastasis.
Pyaskovskaya ON; Kolesnik DL; Garmanchouk LV; Yanish YuV; Solyanik GI
Exp Oncol; 2021 Jun; 43(2):104-110. PubMed ID: 34190519
[TBL] [Abstract][Full Text] [Related]
11. Metabolic consequences of lactate dehydrogenase inhibition by oxamate in hyperglycemic proximal tubular cells.
Wang Z; Nielsen PM; Laustsen C; Bertelsen LB
Exp Cell Res; 2019 May; 378(1):51-56. PubMed ID: 30836064
[TBL] [Abstract][Full Text] [Related]
12. Effective inhibition of nasopharyngeal carcinoma in vitro and in vivo by targeting glycolysis with oxamate.
Li X; Lu W; Hu Y; Wen S; Qian C; Wu W; Huang P
Int J Oncol; 2013 Nov; 43(5):1710-8. PubMed ID: 23982861
[TBL] [Abstract][Full Text] [Related]
13. Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway.
Zhao Z; Han F; Yang S; Wu J; Zhan W
Cancer Lett; 2015 Mar; 358(1):17-26. PubMed ID: 25524555
[TBL] [Abstract][Full Text] [Related]
14. Immunological hallmarks of cis-DDP-resistant Lewis lung carcinoma cells.
Fedorchuk O; Susak Y; Rudyk M; Senchylo N; Khranovska N; Skachkova O; Skivka L
Cancer Chemother Pharmacol; 2018 Feb; 81(2):373-385. PubMed ID: 29290023
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells.
Zhai X; Yang Y; Wan J; Zhu R; Wu Y
Oncol Rep; 2013 Dec; 30(6):2983-91. PubMed ID: 24064966
[TBL] [Abstract][Full Text] [Related]
16. Impact of lactic acidosis on the survival of Lewis lung carcinoma cells.
Kolesnik DL; Pyaskovskaya ON; Solyanik GI
Exp Oncol; 2017 Jul; 39(2):112-116. PubMed ID: 29483490
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of aconitine-containing herbal extract BC1.
Solyanik GI; Fedorchuk AG; Pyaskovskaya ON; Dasyukevitch OI; Khranovskaya NN; Aksenov GN; Sobetsky VV
Exp Oncol; 2004 Dec; 26(4):307-11. PubMed ID: 15627064
[TBL] [Abstract][Full Text] [Related]
18. Lactate Dehydrogenase Inhibition With Oxamate Exerts Bone Anabolic Effect.
Hollenberg AM; Smith CO; Shum LC; Awad H; Eliseev RA
J Bone Miner Res; 2020 Dec; 35(12):2432-2443. PubMed ID: 32729639
[TBL] [Abstract][Full Text] [Related]
19. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment.
Cassim S; Raymond VA; Dehbidi-Assadzadeh L; Lapierre P; Bilodeau M
Cell Cycle; 2018; 17(7):903-916. PubMed ID: 29633904
[TBL] [Abstract][Full Text] [Related]
20. Effects of the suppression of lactate dehydrogenase A on the growth and invasion of human gastric cancer cells.
Liu X; Yang Z; Chen Z; Chen R; Zhao D; Zhou Y; Qiao L
Oncol Rep; 2015 Jan; 33(1):157-62. PubMed ID: 25394466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
